Slow-binding inhibition of gamma-aminobutyric acid aminotransferase by hydrazine analogues.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Medicinal Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 8576911
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The behavior and significance of slow-binding enzyme inhibitors.

  2006cited by this paper
• Time-dependent inhibition of gamma-aminobutyric acid aminotransferase, by 3-hydroxybenzylhydrazine.

  1995cited by this paper
• Effects of two substituted hydrazine monoamine oxidase (MAO) inhibitors on neurotransmitter amines, gamma-aminobutyric acid, and alanine in rat brain.

  1993cited by this paper
• Separation of L-Pro-DL-boroPro into its component diastereomers and kinetic analysis of their inhibition of dipeptidyl peptidase IV. A new method for the analysis of slow, tight-binding inhibition.

  1993cited by this paper
• Cofactor-directed inactivation by nucleophilic amines of the quinoprotein methylamine dehydrogenase from Paracoccus denitrificans.

  1992cited by this paper
• Effects of the antidepressant/antipanic drug phenelzine on GABA concentrations and GABA-transaminase activity in rat brain.

  1992cited by this paper
• Inactivation of gamma-aminobutyric acid aminotransferase by various amine buffers.

  1992cited by this paper
• Inhibition of cytoplasmic aspartate aminotransferase from porcine heart by R and S isomers of aminooxysuccinate and hydrazinosuccinate.

  1991cited by this paper
• Design of potential anticonvulsant agents: mechanistic classification of GABA aminotransferase inactivators.

  1989cited by this paper
• Inhibitors of brain GABA aminotransferase.

  1989cited by this paper
• The reversible oxidation of vicinal SH groups in 4-aminobutyrate aminotransferase. Probes of conformational changes.

  1987cited by this paper
• Inhibition of aspartate aminotransferase by D-hydrazinosuccinate: comparison with L-hydrazinosuccinate.

  1986cited by this paper
• Slow- and tight-binding inhibition of aspartate aminotransferase by L-hydrazinosuccinate.

  1985cited by this paper
• 4-Aminobutyrate aminotransferase. Conformational changes induced by reduction of pyridoxal 5-phosphate.

  1985cited by this paper
• 4-Aminobutyrate aminotransferase. Different susceptibility to inhibitors, microenvironment of the cofactor binding site and distance of the catalytic sites.

  1982cited by this paper
• Regression analysis, experimental error, and statistical criteria in the design and analysis of experiments for discrimination between rival kinetic models.

  1982cited by this paper
• The pharmacology of GABA-transaminase inhibitors.

  1981cited by this paper
• 4-Aminobutyrate aminotransferase. The presence of nonequivalent binding sites.

  1981cited by this paper
• An analysis of the kinetics of the inhibition of rabbit brain gamma-aminobutyrate aminotransferase by sodium n-dipropylacetate and some other simple carboxylic acids.

  1975cited by this paper
• SOME EFFECTS OF MONOAMINE OXIDASE INHIBITORS ON THE METABOLISM OF γ‐AMINOBUTYRIC ACID IN RAT BRAIN

  1969cited by this paper
• Hydrazinopropionic acid: a new inhibitor of aminobutyrate transaminase and glutamate decarboxylase.

  1968cited by this paper
• Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase.

  1962cited by this paper
• Elevation of gamma-aminobutyric acid in brain: selective inhibition of gamma-aminobutyric-alpha-ketoglutaric acid transaminase.

  1961cited by this paper
• Studies on the GABA pathway. I. The inhibition of gamma-aminobutyric acid-alpha-ketoglutaric acid transaminase in vitro and in vivo by U-7524 (amino-oxyacetic acid).

  1961cited by this paper
• The inhibition of gamma aminobutyric-alpha-ketoglutaric acid transaminase in vitro and in vivo by amino-oxyacetic acid.

  1960cited by this paper

• Emerging therapeutic drug targets in amino acid and protein biosynthesis pathways against ESKAPE and non-ESKAPE pathogens: a comprehensive review

  2026cites this paper
• Enhanced Accumulation of Cisplatin in Ovarian Cancer Cells from Combination with Wedelolactone and Resulting Inhibition of Multiple Epigenetic Drivers

  2021cites this paper
• Crystal Structures of Cystathionine β-Synthase from Saccharomyces cerevisiae: One Enzymatic Step at a Time.

  2018cites this paper
• Metabolomics of Hydrazine-Induced Hepatotoxicity in Rats for Discovering Potential Biomarkers

  2018cites this paper
• Metabolic suppression identifies new antibacterial inhibitors under nutrient limitation

  2013cites this paper
• Ambident reactivities of methylhydrazines.

  2012cites this paper
• Pharmacometabonomic characterization of xenobiotic and endogenous metabolic phenotypes that account for inter-individual variation in isoniazid-induced toxicological response.

  2012cites this paper
• Inhibition of human serine racemase, an emerging target for medicinal chemistry.

  2011cites this paper
• GC‐MS‐based metabolomics reveals mechanism of action for hydrazine induced hepatotoxicity in rats

  2011cites this paper
• Kinetic and inhibition studies of dihydroxybenzoate-AMP ligase from Escherichia coli.

  2010cites this paper
• A General Model for Autocatalytic Zymogen Activation Inhibited by Two Different and Mutually Exclusive Inhibitors

  2010cites this paper
• Gut microbiome modulates the toxicity of hydrazine: a metabonomic study.

  2009cites this paper
• Inhibitors of bacterial cystathionine beta-lyase: leads for new antimicrobial agents and probes of enzyme structure and function.

  2007cites this paper
• Protective Effect of Picroliv Against Hydrazine-Induced Hyperlipidemia and Hepatic Steatosis in Rats

  2007cites this paper
• Inactivation of GABA transaminase by 4-acryloylphenol.

  2006cites this paper
• Comparative metabonomics of differential hydrazine toxicity in the rat and mouse.

  2005cites this paper
• On the binding of monoamine oxidase inhibitors to some sites distinct from the MAO active site, and effects thereby elicited.

  2004cites this paper
• Phenylethylidenehydrazine, a novel GABA-transaminase inhibitor, reduces epileptiform activity in rat hippocampal slices.

  2004cites this paper
• Kinetic analysis of enzyme reactions with slow-binding inhibition.

  1999cites this paper
• The effect of tyrosine-deficient total parenteral nutrition on the synthesis of dihydroxyphenylalanine in neural tissue and the activities of tyrosine and branched-chain aminotransferases.

  1998cites this paper